Literature DB >> 15237433

Helicobacter pylori lipopolysaccharide: biological activities in vitro and in vivo, pathological correlation to human chronic gastritis and peptic ulcer.

Yi-Hui Luo1, Jie Yan, Ya-Fei Mao.   

Abstract

AIM: To determine the biological activity of Helicobacter pylori (H. pylori) lipopolysaccharide (H-LPS) and understand pathological correlation between H-LPS and human chronic gastritis and peptic ulcer.
METHODS: H-LPS of a clinical H. pylori strain and LPS of Escherichia coli strain O55:B5 (E-LPS) were extracted by phenol-water method. Biological activities of H-LPS and E-LPS were detected by limulus lysate assay, pyrogen assay, blood pressure test and PBMC induction test in rabbits, cytotoxicity test in NIH 3T3 fibroblast cells and lethality test in NIH mice. By using self-prepared rabbit anti-H-LPS serum as the first antibody and commercial HRP-labeled sheep anti-rabbit sera as the second antibody, H-LPS in biopsy specimens from 126 patients with chronic gastritis (68 cases) or gastric ulcer (58 cases) were examined by immunohistochemistry.
RESULTS: Fibroblast cytotoxicity and mouse lethality of H-LPS were weaker than those of E-LPS. But the ability of coagulating limulus lysate of the two LPSs was similar (+/0.5 ng/mL). At 0.5 h after H-LPS injection, the blood pressures of the 3 rabbits rapidly declined. At 1.0 h after H-LPS injection, the blood pressures in 2 of the 3 rabbits fell to zero causing death of the 2 animals. For the other one rabbit in the same group, its blood pressure gradually elevated. At 0.5 h after E-LPS injection, the blood pressures of the three rabbits also quickly declined and then maintained at low level for approximately 1.0 h. At 0.5 h after injection with H-LPS or E-LPS, PBMC numbers of the rabbits showed a remarkable increase. The total positivity rate of H-LPS from 126 biopsy specimens was 60.3%(76/126). H-LPS positivity rate in the biopsy specimens from chronic gastritis (50/68, 73.5%) was significantly higher than that from gastric ulcer (26/58, 44.8%) (chi(2)=10.77, P<0.01). H-LPS positivity rates in biopsy specimens from chronic superficial gastritis (38/48, 79.2%) and chronic active gastritis (9/10, 90.0%) were significantly higher than that of the patients with atrophic gastritis (3/10, 30.0%) (chi(2)=7.50-9.66, P<0.01).
CONCLUSION: The biological activities of H-LPS were weaker than those of E-LPS, the activities of H-LPS of lowering rabbit blood pressure and inducing rabbit PBMC were relatively stronger. H-LPS may play a critical role in inducing inflammatory reaction in human gastritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237433      PMCID: PMC4572332          DOI: 10.3748/wjg.v10.i14.2055

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  Rho GTPases as therapeutic targets for the treatment of inflammatory diseases.

Authors:  Dezheng Zhao; Charalabos Pothoulakis
Journal:  Expert Opin Ther Targets       Date:  2003-10       Impact factor: 6.902

2.  Non-standard biological activities of lipopolysaccharide from Helicobacter pylori.

Authors:  Naohiro Matsuyama; Teruo Kirikae; Fumiko Kirikae; Masahito Hashimoto; Ken-Ichi Amano; Shunji Hayashi; Yoshikazu Hirai; Tatsuya Kubota; Masayasu Nakano
Journal:  J Med Microbiol       Date:  2001-10       Impact factor: 2.472

3.  The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis.

Authors:  T Sakagami; J Vella; M F Dixon; J O'Rourke; F Radcliff; P Sutton; T Shimoyama; K Beagley; A Lee
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Effect of in vivo infusion of granulocyte colony-stimulating factor on immune function.

Authors:  John F Valente; J Wesley Alexander; Bing-Guo Li; J Gregory Noel; David A Custer; James D Ogle; Cora K Ogle
Journal:  Shock       Date:  2002-01       Impact factor: 3.454

5.  Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.

Authors:  M Suganuma; M Kurusu; S Okabe; N Sueoka; M Yoshida; Y Wakatsuki; H Fujiki
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

6.  Chemical structure and biological activity of a lipid A component from Helicobacter pylori strain 206.

Authors:  Y Suda; Y M Kim; T Ogawa; N Yasui; Y Hasegawa; W Kashihara; T Shimoyama; K Aoyama; K Nagata; T Tamura; S Kusumoto
Journal:  J Endotoxin Res       Date:  2001

7.  Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions.

Authors:  Z Zhang; Y Yuan; H Gao; M Dong; L Wang; Y H Gong
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

8.  Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506).

Authors:  T Ogawa; Y Suda; W Kashihara; T Hayashi; T Shimoyama; S Kusumoto; T Tamura
Journal:  Vaccine       Date:  1997-10       Impact factor: 3.641

9.  Immune changes in patients with colorectal cancer treated by adjuvant therapy with monoclonal antibody 17-1A: a pilot study.

Authors:  O E Tsitsilonis; N B Tsavaris; C Kosmas; P Gouveris; E Papalambros
Journal:  J Chemother       Date:  2003-08       Impact factor: 1.714

10.  Increased in-vitro and in-vivo biological activity of lipopolysaccharide extracted from clinical low virulence vacA genotype Helicobacter pylori strains.

Authors:  Fernando Salgado; Apolinaria García; Angel Oñate; Carlos González; Fernando Kawaguchi
Journal:  J Med Microbiol       Date:  2002-09       Impact factor: 2.472

View more
  5 in total

1.  Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent.

Authors:  Ludwig Deml; Michael Aigner; Jochen Decker; Alexander Eckhardt; Christian Schütz; Peer R E Mittl; Sascha Barabas; Stefanie Denk; Gertrud Knoll; Norbert Lehn; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells.

Authors:  Katharina Kranzer; Liane Söllner; Michael Aigner; Norbert Lehn; Ludwig Deml; Michael Rehli; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Acyl chain specificity of the acyltransferases LpxA and LpxD and substrate availability contribute to lipid A fatty acid heterogeneity in Porphyromonas gingivalis.

Authors:  Brian W Bainbridge; Lisa Karimi-Naser; Robert Reife; Fleur Blethen; Robert K Ernst; Richard P Darveau
Journal:  J Bacteriol       Date:  2008-05-02       Impact factor: 3.490

4.  Bioactivity and immunological evaluation of LPS from different serotypes of Helicobacter pylori.

Authors:  Davoud Esmaeilli; Ashraf Mohabati Mobarez; Ali Hatef Salmanian; Ahmad Zavaran Hosseini
Journal:  Iran J Microbiol       Date:  2013-06

Review 5.  An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment.

Authors:  Yi Ying Cheok; Chalystha Yie Qin Lee; Heng Choon Cheong; Jamuna Vadivelu; Chung Yeng Looi; Suhailah Abdullah; Won Fen Wong
Journal:  Microorganisms       Date:  2021-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.